@PAVEL

The KISS1 metastasis suppressor: A good night kiss for disseminated cancer cells

Structural insights into human brain–gut peptide cholecystokinin receptors

Structural insights into human brain–gut peptide cholecystokinin receptors

Mapping the follicle-stimulating hormone-induced signaling networks

A Novel Mutation in the FSH Receptor Inhibiting Signal Transduction and Causing Primary Ovarian Failure

Role of the intracellular domains of the human FSH receptor in GαS protein coupling and receptor expression

A strong neuroprotective effect of the autonomous C‐terminal peptide of IGF‐1 Ec (MGF) in brain ischemia

Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls

The effect of recombinant human growth hormone and resistance training on IGF‐I mRNA expression in the muscles of elderly men

Overload training inhibits phagocytosis and ROS generation of peritoneal macrophages: role of IGF-1 and MGF

Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?

Ageing is associated with diminished muscle re‐growth and myogenic precursor cell expansion early after immobility‐induced atrophy in human skeletal muscle

Structure and dynamics of the active human parathyroid hormone receptor-1

Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma

Proglucagon-Derived Peptides as Therapeutics

Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis

Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin

LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor

Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects

Transport of circulating IGF-I and LR3IGF-I from blood to extracellular wound fluid sites in rats

First-in-man study with a novel PEGylated recombinant human insulin-like growth factor-I

Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects

Transport of circulating IGF-I and LR3IGF-I from blood to extracellular wound fluid sites in rats

The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins.

Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer

Mechanisms underlying the tissue-specific and regulated activity of the Gnrhr promoter in mammals

Intrinsic and Regulated Gonadotropin-Releasing Hormone Receptor Gene Transcription in Mammalian Pituitary Gonadotrophs

Effect of increasing GnRH and PGF2α dose during Double-Ovsynch on ovulatory response, luteal regression, and fertility of lactating dairy cows

Hypothalamic neurohormones and immune responses

Intrinsic and Regulated Gonadotropin-Releasing Hormone Receptor Gene Transcription in Mammalian Pituitary Gonadotrophs

Extensive structure–activity studies of lactam derivatives of MT‐II and SHU‐9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5

Role of α-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation

Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016

RM-493, a Melanocortin-4 Receptor (MC4R) Agonist, Increases Resting Energy Expenditure in Obese Individuals

Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction

The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids

RM-493, a Melanocortin-4 Receptor (MC4R) Agonist, Increases Resting Energy Expenditure in Obese Individuals

Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction

Extensive structure–activity studies of lactam derivatives of MT‐II and SHU‐9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system

An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance

Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease

Thermoregulatory and thermal control in the human cutaneous circulation

VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy

POMC: The Physiological Power of Hormone Processing

The role of peptide YY in appetite regulation and obesity

Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults

A Single Nucleotide Polymorphism of the Neuropeptide B/W Receptor-1 Gene Influences the Evaluation of Facial Expressions

Evolution of vertebrate opioid receptors

The Role of Neuropeptide B and Its Receptors in Controlling Appetite, Metabolism, and Energy Homeostasis

Evolution of vertebrate opioid receptors

Neuropeptide B and W: neurotransmitters in an emerging G‐protein‐coupled receptor system

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults

The role of peptide YY in appetite regulation and obesity

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults

The satiety hormone peptide YY as a regulator of appetite

Twice-Weekly Administration of Kisspeptin-54 for 8 Weeks Stimulates Release of Reproductive Hormones in Women With Hypothalamic Amenorrhea

Subcutaneous Injection of Kisspeptin-54 Acutely Stimulates Gonadotropin Secretion in Women with Hypothalamic Amenorrhea, But Chronic Administration Causes Tachyphylaxis

Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system

Modulations of human resting brain connectivity by kisspeptin enhance sexual and emotional functions

The Effects of Kisspeptin-10 on Reproductive Hormone Release Show Sexual Dimorphism in Humans

Administration of Kisspeptin‐54 into Discrete Regions of the Hypothalamus Potently Increases Plasma Luteinising Hormone and Testosterone in Male Adult Rats

The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction

Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males

Kisspeptin-54 Stimulates Gonadotropin Release Most Potently during the Preovulatory Phase of the Menstrual Cycle in Women

Subcutaneous Injection of Kisspeptin-54 Acutely Stimulates Gonadotropin Secretion in Women with Hypothalamic Amenorrhea, But Chronic Administration Causes Tachyphylaxis

Kisspeptin as a Behavioral Hormone

Comparative Evolutionary Histories of Kisspeptins and Kisspeptin Receptors in Vertebrates Reveal Both Parallel and Divergent Features

Structure and Developmental Expression of the Mouse CCK-B Receptor Gene

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Cholecystokinin

Human Pharmacokinetics and Tolerability of L‐365,260, a Novel Cholecystokinin‐B Antagonist

The evolution of vertebrate opioid receptors

Characterisation and visualisation of [3H]dermorphin binding to μ opioid receptors in the rat brain

Genetic and functional analysis of a Pacific hagfish opioid system

Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates

Mu Opioids and Their Receptors: Evolution of a Concept

Genetic and functional analysis of a Pacific hagfish opioid system

Untangling the complexity of opioid receptor function

Cloning of a Delta Opioid Receptor by Functional Expression

PHARMACOLOGICAL DATA ON DERMORPHINS, A NEW CLASS OF POTENT OPIOID PEPTIDES FROM AMPHIBIAN SKIN

Mu Opioids and Their Receptors: Evolution of a Concept

Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates

Cloning of a Delta Opioid Receptor by Functional Expression

Untangling the complexity of opioid receptor function

Characterisation and visualisation of [3H]dermorphin binding to μ opioid receptors in the rat brain

Genetic and functional analysis of a Pacific hagfish opioid system

PHARMACOLOGICAL DATA ON DERMORPHINS, A NEW CLASS OF POTENT OPIOID PEPTIDES FROM AMPHIBIAN SKIN

Mu Opioids and Their Receptors: Evolution of a Concept

Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates

The evolution of vertebrate opioid receptors

Cloning of a Delta Opioid Receptor by Functional Expression

Untangling the complexity of opioid receptor function

Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives

Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction

An Effect on the Subjective Sexual Response in Premenopausal Women with Sexual Arousal Disorder by Bremelanotide (PT-141), a Melanocortin Receptor Agonist

Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016

Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

Salvage of Sildenafil Failures With Bremelanotide: A Randomized, Double-Blind, Placebo Controlled Study

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Structure of the agonist-bound neurotensin receptor

Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell lines

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Structure of the agonist-bound neurotensin receptor

The neurotensin receptor‐1 promotes tumor development in a sporadic but not an inflammation‐associated mouse model of colon cancer

Structure of the neurotensin receptor 1 in complex with β-arrestin 1

The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1)

The signaling signature of the neurotensin type 1 receptor with endogenous ligands

Opioid Receptor Types Selectively Cointernalize with G Protein-Coupled Receptor Kinases 2 and 3

PHARMACOLOGICAL DATA ON DERMORPHINS, A NEW CLASS OF POTENT OPIOID PEPTIDES FROM AMPHIBIAN SKIN

D-Alanine in the Frog Skin Peptide Dermorphin Is Derived from L-Alanine in the Precursor

Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine

Detection, quantification, and identification of dermorphin in equine plasma and urine by LC–MS/MS for doping control

Opioid Receptor Types Selectively Cointernalize with G Protein-Coupled Receptor Kinases 2 and 3

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

The Expression and Function of Glucose-Dependent Insulinotropic Polypeptide in the Embryonic Mouse Pancreas

Human Gastric Inhibitory Polypeptide Receptor: Cloning of the Gene (GIPR) and cDNA

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

GIP and GLP‐1, the two incretin hormones: Similarities and differences

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

Human Gastric Inhibitory Polypeptide Receptor: Cloning of the Gene (GIPR) and cDNA

GIP and GLP‐1, the two incretin hormones: Similarities and differences

The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin

Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections

The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone

GIP and GLP‐1, the two incretin hormones: Similarities and differences

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats

Growth Hormone-Releasing Peptide-6 Stimulates Sleep, Growth Hormone, ACTH and Cortisol Release in Normal Man

Oral Administration of Growth Hormone (GH) Releasing Peptide-Mimetic MK-677 Stimulates the GH/Insulin-Like Growth Factor-I Axis in Selected GH-Deficient Adults1

Distribution and Function of Neuropeptides W/B Signaling System

NPBWR1 and NPBWR2: Implications in Energy Homeostasis, Pain, and Emotion

Critical Role of Neuropeptides B/W Receptor 1 Signaling in Social Behavior and Fear Memory

A Role for Neuropeptide W in the Regulation of Feeding Behavior

A Single Nucleotide Polymorphism of the Neuropeptide B/W Receptor-1 Gene Influences the Evaluation of Facial Expressions

Neuropeptide B and W: neurotransmitters in an emerging G‐protein‐coupled receptor system

Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential

Structural insights into human brain–gut peptide cholecystokinin receptors

An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13

Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes

Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis

POMC: The Physiological Power of Hormone Processing

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

Family of melanocortin receptor (MCR) genes in mammals—mutations, polymorphisms and phenotypic effects

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Calcitonin and calcitonin receptors: bone and beyond

Expression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Structure/Function Relationships of Calcitonin Analogues as Agonists, Antagonists, or Inverse Agonists in a Constitutively Activated Receptor Cell System

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

Dissection of the Anti-Inflammatory Effect of the Core and C-Terminal (KPV) α-Melanocyte-Stimulating Hormone Peptides

The melanocortin pathway and energy homeostasis: From discovery to obesity therapy

Extensive structure–activity studies of lactam derivatives of MT‐II and SHU‐9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5

Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction

Risks of unregulated use of alpha‐melanocyte‐stimulating hormone analogues: a review

The Melanocortin-4 Receptor Is Expressed in Enteroendocrine L Cells and Regulates the Release of Peptide YY and Glucagon-like Peptide 1 In Vivo

The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids

RM-493, a Melanocortin-4 Receptor (MC4R) Agonist, Increases Resting Energy Expenditure in Obese Individuals

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Calcitonin and calcitonin receptors: bone and beyond

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes

An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13

Structural basis of cholecystokinin receptor binding and regulation

Structure/Function Relationships of Calcitonin Analogues as Agonists, Antagonists, or Inverse Agonists in a Constitutively Activated Receptor Cell System

Ligand binding and activation of the CGRP receptor

The Molecular Control of Calcitonin Receptor Signaling

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Structure/Function Relationships of Calcitonin Analogues as Agonists, Antagonists, or Inverse Agonists in a Constitutively Activated Receptor Cell System

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Galanin Receptors and Ligands

Cloning and Expressional Characterization of a Novel Galanin Receptor

Galanin (2–11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes

Cloned Human and Rat Galanin GALR3 Receptors

Galanin receptors as a potential target for neurological disease

Molecular cloning of a functional human galanin receptor.

hCG: Biological Functions and Clinical Applications

Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro

Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro

hCG: Biological Functions and Clinical Applications

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

Family of melanocortin receptor (MCR) genes in mammals—mutations, polymorphisms and phenotypic effects

POMC: The Physiological Power of Hormone Processing

Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis

Intracellular signaling mechanisms of the melanocortin receptors: current state of the art

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis

Determination of the melanocortin-4 receptor structure identifies Ca 2+ as a cofactor for ligand binding

Structure and function of the melanocortin2 receptor accessory protein (MRAP)

POMC: The Physiological Power of Hormone Processing

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis

POMC: The Physiological Power of Hormone Processing

Intracellular signaling mechanisms of the melanocortin receptors: current state of the art

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Melanocortin 5 receptor signaling pathway in health and disease

Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis.

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

Melanocortin 5 receptor signaling pathway in health and disease

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Determination of the melanocortin-4 receptor structure identifies Ca 2+ as a cofactor for ligand binding

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

Family of melanocortin receptor (MCR) genes in mammals—mutations, polymorphisms and phenotypic effects

Approaches to the rational design of selective melanocortin receptor antagonists

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Present at the beginning: a personal reminiscence on the history of teriparatide

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors

Abaloparatide: A review of preclinical and clinical studies

Mechanisms of Ligand Binding to the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor: Selectivity of a Modified PTH(1–15) Radioligand for GαS-Coupled Receptor Conformations

Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling

PTH/PTHrP Receptor Signaling, Allostery, and Structures

Structure and dynamics of the active human parathyroid hormone receptor-1

Calcitonin and calcitonin receptors: bone and beyond

Distribution and Function of Neuropeptides W/B Signaling System

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

The role of peptide YY in appetite regulation and obesity

The effect of an opiate antagonist on the hormonal changes induced by hexarelin

The Growth Hormone Secretagogue Receptor: Its Intracellular Signaling and Regulation

Prolonged Oral Treatment with MK-677, a Novel Growth Hormone Secretagogue, Improves Sleep Quality in Man

Growth hormone-releasing peptides

Treatment with the Oral Growth Hormone Secretagogue MK-677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males

Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing’s disease: Comparison with GH-releasing peptide-6 (GHRP-6) and GHRH

Growth hormone response to GHRH + GHRP-6 in type 2 diabetes during euglycemic and hyperglycemic clamp

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

The role of peptide YY in appetite regulation and obesity

The satiety hormone peptide YY as a regulator of appetite

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

Peptide YY: more than just an appetite regulator

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Ligand binding and activation of the CGRP receptor

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Calcitonin and calcitonin receptors: bone and beyond

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Calcitonin: Physiology or fantasy?

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Calcitonin and calcitonin receptors: bone and beyond

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Calcitonin: Physiology or fantasy?

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

The Growth Hormone Secretagogue Receptor: Its Intracellular Signaling and Regulation

The effect of an opiate antagonist on the hormonal changes induced by hexarelin

Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment

Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics

Molecular cloning of the human cholecystokinin gene by use of a synthetic probe containing deoxyinosine.

Cholecystokinin—From Local Gut Hormone to Ubiquitous Messenger

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic Disorder

Natural and Synthetic CCK‐58

CHOLECYSTOKININ CELLS

Cloned cDNA to cholecystokinin mRNA predicts an identical preprocholecystokinin in pig brain and gut.

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Structure of the agonist-bound neurotensin receptor

Structure of the neurotensin receptor 1 in complex with β-arrestin 1

The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1)

The signaling signature of the neurotensin type 1 receptor with endogenous ligands

Feeling at home: Structure of the NTSR1–Gi complex in a lipid environment

The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

Melanocortin 5 receptor signaling pathway in health and disease

POMC: The Physiological Power of Hormone Processing

The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

Melanocortin 5 receptor signaling pathway in health and disease

The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

POMC: The Physiological Power of Hormone Processing

The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids

Approaches to the rational design of selective melanocortin receptor antagonists

POMC: The Physiological Power of Hormone Processing

Structure and function of the melanocortin2 receptor accessory protein (MRAP)

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Neurokinin‐1 receptor: functional significance in the immune system in reference to selected infections and inflammation

Substance P and the Neurokinin-1 Receptor: The New CRF

Substance P and the Neurokinin-1 Receptor: The New CRF

Neurokinin‐1 receptor: functional significance in the immune system in reference to selected infections and inflammation

Substance P and the Neurokinin-1 Receptor: The New CRF

Neurokinin‐1 receptor: functional significance in the immune system in reference to selected infections and inflammation

PAC1 Receptor Internalization and Endosomal MEK/ERK Activation Is Essential for PACAP-Mediated Neuronal Excitability

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

Pituitary adenylate cyclase‐activating polypeptide receptors in the trigeminovascular system: implications for migraine

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus

Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor

Cholecystokinin—From Local Gut Hormone to Ubiquitous Messenger

Substance P and the Neurokinin-1 Receptor: The New CRF

Calcitonin and calcitonin receptors: bone and beyond

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Calcitonin and calcitonin receptors: bone and beyond

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

Structure of the agonist-bound neurotensin receptor

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Structure of the agonist-bound neurotensin receptor

Emerging role of neurotensin in regulation of the cardiovascular system

Twice-Weekly Administration of Kisspeptin-54 for 8 Weeks Stimulates Release of Reproductive Hormones in Women With Hypothalamic Amenorrhea

The Effects of Kisspeptin-10 on Reproductive Hormone Release Show Sexual Dimorphism in Humans

Kisspeptin Excitation of GnRH Neurons

Subcutaneous Injection of Kisspeptin-54 Acutely Stimulates Gonadotropin Secretion in Women with Hypothalamic Amenorrhea, But Chronic Administration Causes Tachyphylaxis

Kisspeptin as a Behavioral Hormone

Administration of Kisspeptin‐54 into Discrete Regions of the Hypothalamus Potently Increases Plasma Luteinising Hormone and Testosterone in Male Adult Rats

From KISS1 to kisspeptins: An historical perspective and suggested nomenclature

Kisspeptin and Glucose Homeostasis

New understandings of the genetic basis of isolated idiopathic central hypogonadism

Functional and evolutionary insights into vertebrate kisspeptin systems from studies of fish brain

Comparative Evolutionary Histories of Kisspeptins and Kisspeptin Receptors in Vertebrates Reveal Both Parallel and Divergent Features

Kisspeptin: a new marker for human pre-ovulation

International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin Receptor Nomenclature, Distribution, and Function

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Calcitonin and calcitonin receptors: bone and beyond

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism

The Effect of PTH Antagonist BIM-44002 on Serum Calcium and PTH Levels in Hypercalcemic Hyperparathyroid Patients

Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.

Mechanisms of Ligand Binding to the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor: Selectivity of a Modified PTH(1–15) Radioligand for GαS-Coupled Receptor Conformations

Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice

Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential

Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes

Structural basis of cholecystokinin receptor binding and regulation

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes

Structural basis of cholecystokinin receptor binding and regulation

Structural basis of cholecystokinin receptor binding and regulation

Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes

Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes

Structural basis of cholecystokinin receptor binding and regulation

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Dimeric CCK2R radiotheranostic tracers synergize with mTOR inhibition for enhanced tumor therapy

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Structure of the agonist-bound neurotensin receptor

Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell lines

The signaling signature of the neurotensin type 1 receptor with endogenous ligands

Emerging role of neurotensin in regulation of the cardiovascular system

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Calcitonin Receptor Plays a Physiological Role to Protect Against Hypercalcemia in Mice

The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

GIP and GLP‐1, the two incretin hormones: Similarities and differences

Kisspeptin Excitation of GnRH Neurons

International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin Receptor Nomenclature, Distribution, and Function

New understandings of the genetic basis of isolated idiopathic central hypogonadism

The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction

Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system

Kisspeptin and Glucose Homeostasis

Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men

Discovery and Evolutionary History of Gonadotrophin‐Inhibitory Hormone and Kisspeptin: New Key Neuropeptides Controlling Reproduction

Functional and evolutionary insights into vertebrate kisspeptin systems from studies of fish brain

Kisspeptin-54 Stimulates Gonadotropin Release Most Potently during the Preovulatory Phase of the Menstrual Cycle in Women

Distribution and Function of Neuropeptides W/B Signaling System

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

The role of peptide YY in appetite regulation and obesity

Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening

Neuropeptide B and W: neurotransmitters in an emerging G‐protein‐coupled receptor system

Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery

NPBWR1 and NPBWR2: Implications in Energy Homeostasis, Pain, and Emotion

Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety

The satiety hormone peptide YY as a regulator of appetite

Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro

Pharmacoperone Identification for Therapeutic Rescue of Misfolded Mutant Proteins

Hypothalamic neurohormones and immune responses

Recent Development of Non-Peptide GnRH Antagonists

GnRH-(1–5) Transactivates EGFR in Ishikawa Human Endometrial Cells via an Orphan G Protein-Coupled Receptor

Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer

Action and therapeutic potential of oxyntomodulin

Proglucagon-Derived Peptides as Therapeutics

The Discovery and Development of Liraglutide and Semaglutide

Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes

Oxyntomodulin analogue increases energy expenditure via the glucagon receptor

Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

Proglucagon-derived peptides: human physiology and therapeutic potential

Cloning and Expression of a Human Glucagon Receptor

Cloning and Expression of a Human Glucagon Receptor

Proglucagon-Derived Peptides as Therapeutics

Structural basis of G s and G i recognition by the human glucagon receptor

Structure of the full-length glucagon class B G-protein-coupled receptor

The first pediatric case of glucagon receptor defect due to biallelic mutations in GCGR is identified by newborn screening of elevated arginine

Molecular basis for negative regulation of the glucagon receptor

Cloning and Expression of a Human Glucagon Receptor

Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)

The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Action and therapeutic potential of oxyntomodulin

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases

An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance

Vasoactive Intestinal Peptide Protects Salivary Glands against Structural Injury and Secretory Dysfunction via IL-17A and AQP5 Regulation in a Model of Sjögren Syndrome

Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system

Rational development of a high-affinity secretin receptor antagonist

The physiological roles of secretin and its receptor

A Systematic Review of Secretin for Children With Autism Spectrum Disorders

Rational development of a high-affinity secretin receptor antagonist

The structure and function of the glucagon‐like peptide‐1 receptor and its ligands

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

Cloning and Characterization of the Signal Transduction of Four Splice Variants of the Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor

Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus

Molecular Cloning and Functional Expression of a cDNA Encoding a Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor

Pituitary adenylate cyclase-activating polypeptide-induced PAC1 receptor internalization and recruitment of MEK/ERK signaling enhance excitability of dentate gyrus granule cells

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus

Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer

Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones

Pituitary Adenylate Cyclase Activating Polypeptide in Stress-Related Disorders: Data Convergence from Animal and Human Studies

Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity

Pituitary adenylate cyclase-activating polypeptide-induced PAC1 receptor internalization and recruitment of MEK/ERK signaling enhance excitability of dentate gyrus granule cells

Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer

Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones

Physiological Significance of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Nervous System

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system

A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases

Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system

Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease

An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance

Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists

Colonic Delivery of Vasoactive Intestinal Peptide Nanomedicine Alleviates Colitis and Shows Promise as An Oral Capsule

Thermoregulatory and thermal control in the human cutaneous circulation

Vasoactive intestinal peptide (VIP), a putative neurotransmitter of nonadrenergic, noncholinergic (NANC) inhibitory innervation and its relevance to therapy

Molecular Cloning and Functional Expression of a cDNA Encoding a Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor

Molecular Cloning and Functional Expression of Rat cDNAs Encoding the Receptor for Pituitary Adenylate Cyclase Activating Polypeptide (PACAP)

Physiological Significance of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Nervous System

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) as a Growth Hormone (GH)-Releasing Factor in Grass Carp. I. Functional Coupling of Cyclic Adenosine 3′,5′-Monophosphate and Ca2+/Calmodulin-Dependent Signaling Pathways in PACAP-Induced GH Secretion and GH Gene Expression in Grass Carp Pituitary Cells

Cloning and Characterization of the Signal Transduction of Four Splice Variants of the Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones

Synthesis of a novel and potent small-molecule antagonist of PAC1 receptor for the treatment of neuropathic pain

Molecular Cloning and Functional Expression of a cDNA Encoding a Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity

Protective effects of PACAP in ischemia

Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)

Structural basis of G s and G i recognition by the human glucagon receptor

Proglucagon-Derived Peptides as Therapeutics

Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data

A combined activation mechanism for the glucagon receptor

Molecular basis for negative regulation of the glucagon receptor

Structure of the full-length glucagon class B G-protein-coupled receptor

The Discovery and Development of Liraglutide and Semaglutide

Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes

Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)

Cloning and Expression of a Human Glucagon Receptor

Action and therapeutic potential of oxyntomodulin

Structure of the full-length glucagon class B G-protein-coupled receptor

Proglucagon-Derived Peptides as Therapeutics

Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1

Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

The structure and function of the glucagon‐like peptide‐1 receptor and its ligands

Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)

Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes

The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting

Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27

PACAP and its role in primary headaches

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)

Proglucagon-Derived Peptides as Therapeutics

Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

Proglucagon-Derived Peptides as Therapeutics

The structure and function of the glucagon‐like peptide‐1 receptor and its ligands

GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors

Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)

Different domains of the glucagon and glucagon‐like peptide‐1 receptors provide the critical determinants of ligand selectivity

Molecular basis for negative regulation of the glucagon receptor

Cloning and Expressional Characterization of a Novel Galanin Receptor

Galanin (2–11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes

Cloning and Expressional Characterization of a Novel Galanin Receptor

Molecular cloning of a functional human galanin receptor.

Cloned Human and Rat Galanin GALR3 Receptors

Cloning and Expression of the Human Galanin Receptor GalR2

Molecular Characterization and Expression of Cloned Human Galanin Receptors GALR2 and GALR3

An assembly of galanin–galanin receptor signaling network

Galanin (2–11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes

Cloning and Expressional Characterization of a Novel Galanin Receptor

Galanin Receptors Modulate Seizures

Cloned Human and Rat Galanin GALR3 Receptors

G o 2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells

Galanin receptors as a potential target for neurological disease

Galanin-like peptide (GALP) is a hypothalamic regulator of energy homeostasis and reproduction

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2

Cloning and Expressional Characterization of a Novel Galanin Receptor

Galanin Receptors and Ligands

Cloned Human and Rat Galanin GALR3 Receptors

Galanin receptors as a potential target for neurological disease

Cloning and Expression of the Human Galanin Receptor GalR2

Galanin receptors as a potential target for neurological disease

Cloning and Expressional Characterization of a Novel Galanin Receptor

Galanin-like peptide (GALP) is a hypothalamic regulator of energy homeostasis and reproduction

An assembly of galanin–galanin receptor signaling network

Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage

Cloned Human and Rat Galanin GALR3 Receptors

Molecular cloning of a functional human galanin receptor.

Cloning and Expressional Characterization of a Novel Galanin Receptor

Cloned Human and Rat Galanin GALR3 Receptors

An assembly of galanin–galanin receptor signaling network

Cloning and Expression of the Human Galanin Receptor GalR2

International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin Receptor Nomenclature, Distribution, and Function

Kisspeptin Excitation of GnRH Neurons

From KISS1 to kisspeptins: An historical perspective and suggested nomenclature

Discovery and Evolutionary History of Gonadotrophin‐Inhibitory Hormone and Kisspeptin: New Key Neuropeptides Controlling Reproduction

Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system

New understandings of the genetic basis of isolated idiopathic central hypogonadism

Kisspeptin and Glucose Homeostasis

Subcutaneous Injection of Kisspeptin-54 Acutely Stimulates Gonadotropin Secretion in Women with Hypothalamic Amenorrhea, But Chronic Administration Causes Tachyphylaxis

The Effects of Kisspeptin-10 on Reproductive Hormone Release Show Sexual Dimorphism in Humans

The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction

The Growth Hormone Secretagogue Receptor: Its Intracellular Signaling and Regulation

One dose of oral hexarelin protects chronic cardiac function after myocardial infarction

The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist

Beyond Hunger: The Structure, Signaling, and Systemic Roles of Ghrelin

Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor

Identification of the Acyltransferase that Octanoylates Ghrelin, an Appetite-Stimulating Peptide Hormone

Beyond Hunger: The Structure, Signaling, and Systemic Roles of Ghrelin

Angiotensin-converting enzyme in innate and adaptive immunity

Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes

An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13

Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics

Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Galanin Receptors and Ligands

Cloning and Expressional Characterization of a Novel Galanin Receptor

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Structure of the agonist-bound neurotensin receptor

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Calcitonin and calcitonin receptors: bone and beyond

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes

Structural basis of cholecystokinin receptor binding and regulation

Structure of Porcine Cholecystokinin‐Pancreozymin

An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13

Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus

Cloning and Characterization of the Signal Transduction of Four Splice Variants of the Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease

A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases

Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

POMC: The Physiological Power of Hormone Processing

Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis

Melanocortin 5 receptor signaling pathway in health and disease

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases

Melanocortin 5 receptor signaling pathway in health and disease

Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis

POMC: The Physiological Power of Hormone Processing

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Structure of the agonist-bound neurotensin receptor

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin Receptor Nomenclature, Distribution, and Function

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Structure of the agonist-bound neurotensin receptor

Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell lines

Structure of the agonist-bound neurotensin receptor

Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone

GIP and GLP‐1, the two incretin hormones: Similarities and differences

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.

Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

The evolution of vertebrate opioid receptors

Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates

Mu Opioids and Their Receptors: Evolution of a Concept

The evolution of vertebrate opioid receptors

Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes

Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

The structure and function of the glucagon‐like peptide‐1 receptor and its ligands

Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1

The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

The Expression and Function of Glucose-Dependent Insulinotropic Polypeptide in the Embryonic Mouse Pancreas

Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

GIP and GLP‐1, the two incretin hormones: Similarities and differences

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

Natural and Synthetic CCK‐58

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor

Cholecystokinin Revisited: CCK and the Hunger Trap in Anorexia Nervosa

Cholecystokinin—From Local Gut Hormone to Ubiquitous Messenger

Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics

An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13

Human Pharmacokinetics and Tolerability of L‐365,260, a Novel Cholecystokinin‐B Antagonist

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

Physiological Significance of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Nervous System

Pituitary Adenylate Cyclase Activating Polypeptide in Stress-Related Disorders: Data Convergence from Animal and Human Studies

Pituitary adenylate cyclase‐activating polypeptide receptors in the trigeminovascular system: implications for migraine

The structure and function of the glucagon‐like peptide‐1 receptor and its ligands

Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening

Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes

Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor

Different domains of the glucagon and glucagon‐like peptide‐1 receptors provide the critical determinants of ligand selectivity

Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1

Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms

International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin Receptor Nomenclature, Distribution, and Function

Kisspeptin Excitation of GnRH Neurons

Discovery and Evolutionary History of Gonadotrophin‐Inhibitory Hormone and Kisspeptin: New Key Neuropeptides Controlling Reproduction

Subcutaneous Injection of Kisspeptin-54 Acutely Stimulates Gonadotropin Secretion in Women with Hypothalamic Amenorrhea, But Chronic Administration Causes Tachyphylaxis

Kisspeptin and Glucose Homeostasis

The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction

New understandings of the genetic basis of isolated idiopathic central hypogonadism

The Role of Kisspeptin in Sexual Behavior

The Effects of Kisspeptin-10 on Reproductive Hormone Release Show Sexual Dimorphism in Humans

Functional and evolutionary insights into vertebrate kisspeptin systems from studies of fish brain

From KISS1 to kisspeptins: An historical perspective and suggested nomenclature

Kisspeptin-54 Stimulates Gonadotropin Release Most Potently during the Preovulatory Phase of the Menstrual Cycle in Women

Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)

Structure of the full-length glucagon class B G-protein-coupled receptor

Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology

Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction

Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

RM-493, a Melanocortin-4 Receptor (MC4R) Agonist, Increases Resting Energy Expenditure in Obese Individuals

The melanocortin pathway and energy homeostasis: From discovery to obesity therapy

The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids

Alanine Scanning Mutagenesis of the DRYxxI Motif and Intracellular Loop 2 of Human Melanocortin-4 Receptor

Extensive structure–activity studies of lactam derivatives of MT‐II and SHU‐9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5

Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction

Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016

Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

RM-493, a Melanocortin-4 Receptor (MC4R) Agonist, Increases Resting Energy Expenditure in Obese Individuals

The Neuroimmunomodulatory Peptide α‐MSH

Melanocortin 4 Receptor and Dopamine D2 Receptor Expression in Brain Areas Involved in Food Intake

The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids

Characterization of a novel nonpeptide vasopressin V2‐agonist, OPC‐51803, in cells transfected human vasopressin receptor subtypes

Regulation of the Vasopressin V2 Receptor by Vasopressin in Polarized Renal Collecting Duct Cells

Role of cAMP/PKA signaling cascade in vasopressin-induced trafficking of TRPC3 channels in principal cells of the collecting duct

Characterization of a novel nonpeptide vasopressin V2‐agonist, OPC‐51803, in cells transfected human vasopressin receptor subtypes

Regulation of the Vasopressin V2 Receptor by Vasopressin in Polarized Renal Collecting Duct Cells

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Expression of the calcitonin receptor, calcitonin receptor‐like receptor, and receptor activity modifying proteins during osteoclast differentiation

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation

Abaloparatide: A review of preclinical and clinical studies

Present at the beginning: a personal reminiscence on the history of teriparatide

Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling

PTH/PTHrP Receptor Signaling, Allostery, and Structures

Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism

Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy

Parathyroid hormone signaling in bone and kidney

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Parathyroid hormone signaling in bone and kidney

Present at the beginning: a personal reminiscence on the history of teriparatide

Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism

Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long‐Acting PTH

PTH/PTHrP Receptor Signaling, Allostery, and Structures

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long‐Acting PTH

Parathyroid hormone signaling in bone and kidney

Structure and dynamics of the active human parathyroid hormone receptor-1

Present at the beginning: a personal reminiscence on the history of teriparatide

A naturally occurring isoform inhibits parathyroid hormone receptor trafficking and signaling

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Parathyroid hormone signaling in bone and kidney

Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice

Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long‐Acting PTH

A naturally occurring isoform inhibits parathyroid hormone receptor trafficking and signaling

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Structure and dynamics of the active human parathyroid hormone receptor-1

Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice

Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long‐Acting PTH

Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling

Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long‐Acting PTH

Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation

Sustained signalling by PTH modulates IP3 accumulation and IP3 receptors via cyclic AMP junctions

Mechanisms of Ligand Binding to the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor: Selectivity of a Modified PTH(1–15) Radioligand for GαS-Coupled Receptor Conformations

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

The Effect of PTH Antagonist BIM-44002 on Serum Calcium and PTH Levels in Hypercalcemic Hyperparathyroid Patients

Abaloparatide: A review of preclinical and clinical studies

Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling

Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice

PTH/PTHrP Receptor Signaling, Allostery, and Structures

International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors—Family B G Protein–Coupled Receptors

Parathyroid hormone signaling in bone and kidney

Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Structure/Function Relationships of Calcitonin Analogues as Agonists, Antagonists, or Inverse Agonists in a Constitutively Activated Receptor Cell System

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts

Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

Calcitonin Receptor Plays a Physiological Role to Protect Against Hypercalcemia in Mice

N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

The Growth Hormone Secretagogue Receptor: Its Intracellular Signaling and Regulation

The effect of an opiate antagonist on the hormonal changes induced by hexarelin

Treatment with the Oral Growth Hormone Secretagogue MK-677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults

The satiety hormone peptide YY as a regulator of appetite

The role of peptide YY in appetite regulation and obesity

The effect of an opiate antagonist on the hormonal changes induced by hexarelin

Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects

The Growth Hormone Secretagogue Receptor: Its Intracellular Signaling and Regulation

Treatment with the Oral Growth Hormone Secretagogue MK-677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males

Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing’s disease: Comparison with GH-releasing peptide-6 (GHRP-6) and GHRH

Decreased ghrelin-induced GH release in thyrotoxicosis: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH